Join to View Full Profile
1275 York Ave# 1New York, NY 10065
Phone+1 212-639-2000
Dr. Ferng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2015 - 2019
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2010 - 2013
Wayne State University School of MedicineClass of 2010
Certifications & Licensure
CA State Medical License 2015 - 2027
NY State Medical License 2013 - 2016
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Single-center experience with nelarabine, etoposide, and cyclophosphamide in adults with relapsed/refractory T-acute lymphoblastic leukemia/lymphoma.Tamer Othman, Mimi M Lo, Charalambos B Andreadis, Lloyd E Damon, Timothy T Ferng
Leukemia & Lymphoma. 2025-09-01 - 15 citationsThe Irreversible FLT3 Inhibitor FF-10101 Is Active Against a Diversity of FLT3 Inhibitor Resistance Mechanisms.Timothy T Ferng, Daisuke Terada, Makoto Ando, Theodore C Tarver, Fihr Chaudhary
Molecular Cancer Therapeutics. 2022-05-04 - 277 citationsClonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid LeukemiaChristine M. McMahon, Timothy T. Ferng, Jonathan Canaani, Eunice S. Wang, Jennifer J.D. Morrissette
Cancer Discovery. 2019-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
